About Velsera

Medicine moves too slow. At Velsera, we are changing that.

Velsera was formed in 2023 through the shared vision of Seven Bridges and Pierian, with a mission to accelerate the discovery, development, and delivery of life-changing insights.

Velsera provides software and professional services for:

• AI-powered multimodal data harmonization and analytics for drug discovery and development
• IVD development, validation, and regulatory approval
• Clinical NGS interpretation, reporting, and adoption

With our headquarters in Boston, MA, we are growing and expanding our teams located in different countries!

About the role 

Velsera’s Seven Bridges Platform is used by biomedical researchers and pharma teams to run reproducible analyses in regulated environments. We’re adding an AI platform layer to Seven Bridges—model invocation, self-hosted LLM serving, gov...